2023 Q4 Form 10-Q Financial Statement

#000149315223041101 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $31.95K $0.00
YoY Change -90.77%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $31.95K $0.00
YoY Change -85.2%
Gross Profit Margin 100.0%
Selling, General & Admin $443.7K $495.3K $395.1K
YoY Change 349.74%
% of Gross Profit 1388.64%
Research & Development $2.610K $8.803K
YoY Change
% of Gross Profit 8.17%
Depreciation & Amortization $750.00 $250.00
YoY Change
% of Gross Profit 2.35%
Operating Expenses $446.3K $504.1K $395.1K
YoY Change 352.39% 385.38%
Operating Profit -$414.3K -$504.1K -$395.1K
YoY Change -453.46% -5283.14%
Interest Expense $2.540K $2.993K -$340.00
YoY Change -443.24% 93.1%
% of Operating Profit
Other Income/Expense, Net -$2.653K -$342.00
YoY Change 71.16%
Pretax Income -$411.8K -$506.7K -$395.5K
YoY Change -453.51% -6298.32%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$411.8K -$506.7K -$395.5K
YoY Change -453.51% -6298.32% 180.11%
Net Earnings / Revenue -1288.89%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.7M shares 107.7M shares 100.7M shares
Diluted Shares Outstanding 107.7M shares 100.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $204.0K $531.4K $265.7K
YoY Change
Cash & Equivalents $204.0K $531.4K $265.7K
Short-Term Investments
Other Short-Term Assets $29.19K $51.68K $36.21K
YoY Change
Inventory
Prepaid Expenses $29.19K $51.68K
Receivables $31.95K $25.63K
Other Receivables $180.00 $1.230K
Total Short-Term Assets $266.5K $621.4K $328.8K
YoY Change -34.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $71.86K $8.750K
YoY Change
Long-Term Investments
YoY Change
Other Assets $210.6K $179.5K $131.6K
YoY Change
Total Long-Term Assets $282.5K $188.3K $131.6K
YoY Change 132.79%
TOTAL ASSETS
Total Short-Term Assets $266.5K $621.4K $328.8K
Total Long-Term Assets $282.5K $188.3K $131.6K
Total Assets $549.0K $809.6K $460.3K
YoY Change 3.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.38K $141.4K $119.8K
YoY Change
Accrued Expenses $11.58K $0.00 $13.84K
YoY Change -88.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $102.5K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $102.0K $155.8K $236.1K
YoY Change -77.29%
LONG-TERM LIABILITIES
Long-Term Debt $149.9K $149.9K $149.9K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $149.9K $149.9K $149.9K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $102.0K $155.8K $236.1K
Total Long-Term Liabilities $149.9K $149.9K $149.9K
Total Liabilities $251.9K $305.7K $386.0K
YoY Change -57.95%
SHAREHOLDERS EQUITY
Retained Earnings -$5.000M -$4.610M
YoY Change 36.78%
Common Stock $471.6K $471.5K
YoY Change 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $297.1K $503.9K $74.28K
YoY Change
Total Liabilities & Shareholders Equity $549.0K $809.6K $460.3K
YoY Change 3.35%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$411.8K -$506.7K -$395.5K
YoY Change -453.51% -6298.32% 180.11%
Depreciation, Depletion And Amortization $750.00 $250.00
YoY Change
Cash From Operating Activities -$416.4K -$398.8K -$318.0K
YoY Change -8201.75%
INVESTING ACTIVITIES
Capital Expenditures $63.86K $9.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$52.13K -$26.95K -$10.20K
YoY Change -57.05%
Cash From Investing Activities -$116.0K -$35.95K -$10.20K
YoY Change -4.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 205.0K 700.5K 562.4K
YoY Change 340.84%
NET CHANGE
Cash From Operating Activities -416.4K -398.8K -318.0K
Cash From Investing Activities -116.0K -35.95K -10.20K
Cash From Financing Activities 205.0K 700.5K 562.4K
Net Change In Cash -327.4K 265.7K 234.1K
YoY Change 369.64%
FREE CASH FLOW
Cash From Operating Activities -$416.4K -$398.8K -$318.0K
Capital Expenditures $63.86K $9.000K
Free Cash Flow -$480.3K -$407.8K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001771995
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
usd
us-gaap Interest And Other Income
InterestAndOtherIncome
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
APHP Reserve For Uncollectible Receivable
ReserveForUncollectibleReceivable
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
APHP Conversion Of Accrued Expenses Into Options To Purchase Common Stock
ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock
usd
APHP Conversion Of Note Payable To Related Parties And Accrued Interest To Common Stock
ConversionOfNotePayableToRelatedPartiesAndAccruedInterestToCommonStock
usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P3Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56586
dei Entity Registrant Name
EntityRegistrantName
American Picture House Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4154740
dei Entity Address Address Line1
EntityAddressAddressLine1
555 Madison Avenue 5FL
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
1-800
dei Local Phone Number
LocalPhoneNumber
689-6885
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107740991 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
531393 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51684 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
180 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
347 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
621382 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
409776 usd
CY2023Q3 APHP Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
158508 usd
CY2022Q4 APHP Produced And Licensed Content Costs
ProducedAndLicensedContentCosts
121355 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8750 usd
CY2023Q3 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
366387 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
366387 usd
CY2023Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
21000 usd
CY2023Q3 us-gaap Assets
Assets
809640 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
141350 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
14492 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10288 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
14492 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10288 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
155842 usd
CY2023Q3 APHP Economic Injury Disaster Loan Noncurrent
EconomicInjuryDisasterLoanNoncurrent
149900 usd
CY2023Q3 us-gaap Liabilities
Liabilities
305742 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108715991 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108715991 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100735159 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100735159 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
471472 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3829 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3829 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3829 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3829 shares
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4642318 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4609892 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
503898 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
809640 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
169111 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1426 usd
us-gaap Cost Of Revenue
CostOfRevenue
36701 usd
us-gaap Cost Of Revenue
CostOfRevenue
1426 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
113574 usd
us-gaap Gross Profit
GrossProfit
132410 usd
us-gaap Gross Profit
GrossProfit
113574 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
495257 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
103849 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1073980 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
310639 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8803 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8803 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
504060 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
103849 usd
us-gaap Operating Expenses
OperatingExpenses
1082783 usd
us-gaap Operating Expenses
OperatingExpenses
310639 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-504060 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9725 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-950373 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-197065 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
340 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
2793 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
2993 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1550 usd
us-gaap Interest Expense
InterestExpense
6934 usd
us-gaap Interest Expense
InterestExpense
5178 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2653 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1550 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4141 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5178 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-506713 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8175 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-954514 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-202243 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-506713 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
8175 usd
us-gaap Net Income Loss
NetIncomeLoss
-954514 usd
us-gaap Net Income Loss
NetIncomeLoss
-202243 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107740991 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107740991 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98735159 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98735159 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103083257 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103083257 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91735159 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91735159 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-67756 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
105000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
1160221 shares
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
105000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-52339 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-15095 usd
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.15
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
459834 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-395462 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
74277 usd
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.20
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
133333 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
133333 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
803001 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-506713 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
503898 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-307000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-69235 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-376235 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-141183 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-217418 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-217418 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
8175 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
8175 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-209243 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-209243 usd
us-gaap Net Income Loss
NetIncomeLoss
-954514 usd
us-gaap Net Income Loss
NetIncomeLoss
-202243 usd
APHP Reserve For Uncollectible Receivable
ReserveForUncollectibleReceivable
193932 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
158333 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
250 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-150992 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
39822 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5356 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
37888 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-27349 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
182139 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-130000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-35000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
36250 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-716862 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15286 usd
APHP Payments To Produced And Licensed Costs
PaymentsToProducedAndLicensedCosts
37153 usd
APHP Payments To Produced And Licensed Costs
PaymentsToProducedAndLicensedCosts
102724 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46153 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102724 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
178500 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
112760 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
178500 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
66260 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1262835 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1262835 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
499820 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-40938 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31573 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101289 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
531393 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60351 usd
APHP Conversion Of Accrued Expenses Into Options To Purchase Common Stock
ConversionOfAccruedExpensesIntoOptionsToPurchaseCommonStock
105000 usd
APHP Conversion Of Note Payable To Related Parties And Accrued Interest To Common Stock
ConversionOfNotePayableToRelatedPartiesAndAccruedInterestToCommonStock
300000 usd
us-gaap Stock Issued1
StockIssued1
158333 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2023Q3 APHP Working Capital
WorkingCapital
465540 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4609892 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zohp9EzTL3R" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><i><span style="text-decoration: underline"><span id="xdx_864_zlqCttozUpzd">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amount of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.<br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"></span></p>
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
51684 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
32862 usd
CY2023Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
21000 usd
CY2023Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
72684 usd
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
32862 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
531393 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31573 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
250 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
250 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6276422 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6211469 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
250 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
250 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
65000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
105000 usd

Files In Submission

Name View Source Status
0001493152-23-041101-index-headers.html Edgar Link pending
0001493152-23-041101-index.html Edgar Link pending
0001493152-23-041101.txt Edgar Link pending
0001493152-23-041101-xbrl.zip Edgar Link pending
aphp-20230930.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
ex10-1_003.jpg Edgar Link pending
ex10-1_004.jpg Edgar Link pending
ex10-1_005.jpg Edgar Link pending
ex10-1_006.jpg Edgar Link pending
ex10-1_1.htm Edgar Link pending
ex10-1_1001.jpg Edgar Link pending
ex10-1_1002.jpg Edgar Link pending
ex10-1_1003.jpg Edgar Link pending
ex10-1_1004.jpg Edgar Link pending
ex10-1_1005.jpg Edgar Link pending
ex10-1_1006.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
ex10-2_017.jpg Edgar Link pending
ex10-2_018.jpg Edgar Link pending
ex10-2_019.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-3_001.jpg Edgar Link pending
ex10-3_002.jpg Edgar Link pending
ex10-3_003.jpg Edgar Link pending
aphp-20230930_pre.xml Edgar Link unprocessable
ex10-3_004.jpg Edgar Link pending
ex10-3_005.jpg Edgar Link pending
ex10-3_006.jpg Edgar Link pending
ex10-3_007.jpg Edgar Link pending
ex10-3_008.jpg Edgar Link pending
ex10-3_009.jpg Edgar Link pending
ex10-3_010.jpg Edgar Link pending
ex10-3_011.jpg Edgar Link pending
ex10-3_012.jpg Edgar Link pending
ex10-3_013.jpg Edgar Link pending
ex10-3_014.jpg Edgar Link pending
ex10-3_015.jpg Edgar Link pending
ex10-4.htm Edgar Link pending
ex10-4_001.jpg Edgar Link pending
ex10-4_002.jpg Edgar Link pending
ex10-4_003.jpg Edgar Link pending
ex10-4_004.jpg Edgar Link pending
ex10-4_005.jpg Edgar Link pending
ex10-4_006.jpg Edgar Link pending
ex10-4_007.jpg Edgar Link pending
ex10-4_008.jpg Edgar Link pending
ex10-4_009.jpg Edgar Link pending
ex10-4_010.jpg Edgar Link pending
ex10-4_011.jpg Edgar Link pending
ex10-4_012.jpg Edgar Link pending
ex10-5.htm Edgar Link pending
ex10-5_001.jpg Edgar Link pending
ex10-5_002.jpg Edgar Link pending
ex10-5_003.jpg Edgar Link pending
ex10-5_004.jpg Edgar Link pending
ex10-5_005.jpg Edgar Link pending
ex10-5_006.jpg Edgar Link pending
ex10-5_007.jpg Edgar Link pending
ex10-5_008.jpg Edgar Link pending
ex10-5_009.jpg Edgar Link pending
ex10-5_010.jpg Edgar Link pending
ex10-6.htm Edgar Link pending
ex10-6_001.jpg Edgar Link pending
ex10-6_002.jpg Edgar Link pending
ex10-6_1.htm Edgar Link pending
ex10-6_1001.jpg Edgar Link pending
ex10-6_1002.jpg Edgar Link pending
ex10-7.htm Edgar Link pending
ex10-7_001.jpg Edgar Link pending
ex10-7_002.jpg Edgar Link pending
ex10-7_003.jpg Edgar Link pending
ex10-7_004.jpg Edgar Link pending
ex10-7_005.jpg Edgar Link pending
ex10-7_006.jpg Edgar Link pending
ex10-7_007.jpg Edgar Link pending
ex10-7_008.jpg Edgar Link pending
ex10-7_009.jpg Edgar Link pending
ex10-7_010.jpg Edgar Link pending
ex10-7_011.jpg Edgar Link pending
ex10-7_012.jpg Edgar Link pending
ex10-8.htm Edgar Link pending
ex10-8_001.jpg Edgar Link pending
ex10-8_002.jpg Edgar Link pending
ex10-8_003.jpg Edgar Link pending
ex10-8_004.jpg Edgar Link pending
ex10-8_005.jpg Edgar Link pending
ex14-1.htm Edgar Link pending
ex14-1_001.jpg Edgar Link pending
ex14-1_002.jpg Edgar Link pending
ex14-1_003.jpg Edgar Link pending
ex14-1_004.jpg Edgar Link pending
ex14-1_005.jpg Edgar Link pending
ex14-2.htm Edgar Link pending
ex14-2_001.jpg Edgar Link pending
ex14-2_002.jpg Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex3-1_003.jpg Edgar Link pending
ex3-1_004.jpg Edgar Link pending
ex3-1_005.jpg Edgar Link pending
ex3-1_006.jpg Edgar Link pending
ex3-1_007.jpg Edgar Link pending
ex3-1_008.jpg Edgar Link pending
ex3-2.htm Edgar Link pending
ex3-2_001.jpg Edgar Link pending
ex3-2_002.jpg Edgar Link pending
ex3-2_003.jpg Edgar Link pending
ex3-2_004.jpg Edgar Link pending
ex3-2_005.jpg Edgar Link pending
ex3-2_006.jpg Edgar Link pending
ex3-2_007.jpg Edgar Link pending
ex3-2_008.jpg Edgar Link pending
ex3-2_009.jpg Edgar Link pending
ex3-2_010.jpg Edgar Link pending
ex3-2_011.jpg Edgar Link pending
ex3-2_012.jpg Edgar Link pending
ex3-2_013.jpg Edgar Link pending
ex3-2_014.jpg Edgar Link pending
ex3-2_015.jpg Edgar Link pending
ex3-2_016.jpg Edgar Link pending
ex3-2_017.jpg Edgar Link pending
ex3-3.htm Edgar Link pending
ex3-3_001.jpg Edgar Link pending
ex3-3_002.jpg Edgar Link pending
ex3-3_003.jpg Edgar Link pending
ex3-3_004.jpg Edgar Link pending
ex3-4.htm Edgar Link pending
ex3-4_001.jpg Edgar Link pending
ex3-4_002.jpg Edgar Link pending
ex3-4_003.jpg Edgar Link pending
ex3-4_004.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10q_htm.xml Edgar Link completed
aphp-20230930_cal.xml Edgar Link unprocessable
aphp-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aphp-20230930_lab.xml Edgar Link unprocessable